Dimethyl fumarate-induced IL-17low IFN-γlow IL-4+ Th cells protect mice from severe encephalomyelitis

Eur J Immunol. 2018 Sep;48(9):1588-1591. doi: 10.1002/eji.201747435. Epub 2018 Aug 22.

Abstract

Dimethyl fumarate (DMF) promotes an IL-17Alow IFN-γlow IL-4+ CD4+ T cell phenotype. Adoptive transfer of in vitro DMF-treated myelin peptide-reactive IL-17Alow IFN-γlow IL-4+ CD4+ T cells prior to immunization for EAE reduces the severity of encephalomyelitis. This beneficial effect of transferred DMF-treated CD4+ T cells requires an early in vivo recall.

Keywords: Dimethyl fumarate; EAE; Immunotherapy; T cell vaccine; Th17 cells.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adoptive Transfer
  • Animals
  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / transplantation
  • Dimethyl Fumarate / pharmacology*
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / prevention & control*
  • Immunosuppressive Agents / pharmacology*
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / immunology*
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / immunology
  • Interleukin-17 / biosynthesis
  • Interleukin-17 / immunology
  • Interleukin-4 / biosynthesis
  • Interleukin-4 / immunology*
  • Mice
  • Th1 Cells / immunology
  • Th17 Cells / immunology*
  • Th2 Cells / immunology

Substances

  • IFNG protein, mouse
  • IL10 protein, mouse
  • Il17a protein, mouse
  • Immunosuppressive Agents
  • Interleukin-17
  • Interleukin-10
  • Interleukin-4
  • Interferon-gamma
  • Dimethyl Fumarate